Browse: Home / Green Cross and Nanolek Announce Strategic Partnership for Biologics Commercialisation in Russia

Menu

Skip to content
  • About Us
  • Contact Us
  • Submit News
Header image

Cambodian TribuneLogo

Latest Cambodian News

Menu

Skip to content
  • Home
  • General
  • Business
  • Entertainment
  • Politics
  • Legal & Judicial
  • PRESS RELEASES
  • Trump: US Trade Talks with China Making 'Big Progress'
  • NYC's Chinatown Welcomes Year of the Pig With Vvibrant Parade
  • UAE's Conglomerate Interested in Investing in Cambodia's Different Sectors
  • Huge Land Loss Predicted for Vietnam's Mekong Delta
  • Foreign Ministry thanks Cambodia over release of 47 Malaysian detainees

Green Cross and Nanolek Announce Strategic Partnership for Biologics Commercialisation in Russia

Posted by admin on March 26, 2015 in Medical and Health Care | 16 Views

YONGIN, South Korea, March 26, 2014 /PRNewswire/ — Green Cross, a South Korean biopharmaceutical company, and Nanolek, a Russian pharmaceutical company, today announced that they have entered into a strategic partnership agreement for the commercialisation of Green Cross’ biologics in the Russian market.

Under the terms of the agreement, Nanolek will obtain marketing authorisations and set up the production of a number of Green Cross’ biologics. The production will be organised at Nanolek’s facility, a state-of-art biopharmaceutical complex built and equipped in compliance with EU GMP standards and launched in December 2014.

"This partnership is a perfect strategic fit for Green Cross’ global business model," said EC Huh, Ph. D., president of Green Cross Corporation. "We are excited to work with the team at Nanolek, and to share in the longer-term commercial success of Green Cross’ products as it enters Russia."

"Our project with Green Cross will make socially significant drugs more accessible and minimize the state’s financial burden for the procurement of these drugs outside of Russia," said Mikhail Nekrasov, CEO of Nanolek. "Making possible the domestic production of a number of biopharmaceuticals is our contribution to the implementation of the government policy in developing the Russian pharmaceutical industry."

Russia’s pharmaceutical market is one of the most attractive in the emerging European region, mainly due to its absolute size, plus a growing economy and increasing government investment in healthcare, according to a report from Business Monitor International. The Russian market is set to grow at twice the pace of the global pharmaceutical market, with growth estimates around 10-15% annually reaching an approximate market value of $43-60 billion by 2020.

About Green Cross

Green Cross provides total healthcare solutions that address the evolving needs of human health. Headquartered in Yongin, South Korea, Green Cross specialises in the development and manufacturing of plasma-derivatives, vaccines and recombinant proteins.

About Nanolek

Nanolek is a Russian fast-growing pharmaceutical company which aims to become one of the market leaders in the production of innovative biotechnological products and modern vaccines, stimulating the creation of the national bio-economy and amplifying the country’s biosafety.

This release includes forward-looking statements concerning Green Cross’ strategic partnership with Nanolek, the commercialization of the company’s biologics in Russia. The statements are based on assumptions about many important factors. The company does not undertake to update its forward-looking statements.

Posted in Medical and Health Care | Tagged BIO, HEA, JVN, MTC, PDT

Related Posts

Missing imageDKSH Supports Growth for Vitabiotics in Hong Kong and Malaysia→

Missing imageSphenopalatine Ganglion Stimulation in the Pathway CH-1 Study Reduces Headache Burden Before and After Sustained Periods of Cluster Attack Remission→

Missing imageLatin American Contract Research Organizations Set to Get More Local Outsourcing Opportunities→

Missing imageChinese doctors get admiration for free treatment in Cambodia (China Daily)→

Search

Pages

  • About Us
  • Contact Us
  • Submit News

Calendar

February 2019
M T W T F S S
« Jan    
 123
45678910
11121314151617
18192021222324
25262728  

Advertisement

Latest News

  • Missing image

    Trump: US Trade Talks with China Making ‘Big Progress’

    February 17, 2019 / admin
  • Missing image

    NYC’s Chinatown Welcomes Year of the Pig With Vvibrant Parade

    February 17, 2019 / admin
  • Missing image

    UAE’s Conglomerate Interested in Investing in Cambodia’s Different Sectors

    February 16, 2019 / admin
  • Missing image

    Huge Land Loss Predicted for Vietnam’s Mekong Delta

    February 16, 2019 / admin
  • Missing image

    Foreign Ministry thanks Cambodia over release of 47 Malaysian detainees

    February 16, 2019 / admin
  • Missing image

    Emirates To Add Phnom Penh-Bangkok Flights to Dubai

    February 16, 2019 / admin
  • Missing image

    Malaysia Thanks Cambodia for Release of 47 Malaysian Detainees

    February 16, 2019 / admin
  • Missing image

    Flight and Passenger Handling Capacity of Cambodia Airports on its Way

    February 15, 2019 / admin
  • Missing image

    PM: Loss of EBA Scheme Not To Much Affect Cambodia

    February 15, 2019 / admin
  • Missing image

    UNESCO Appreciates Cambodia’s Inclusive Education

    February 15, 2019 / admin
  • Facebook
  • Pinterest
  • Tumblr
  • Twitter

Pages

  • About Us
  • Contact Us
  • Submit News
 

Recent Posts

  • Trump: US Trade Talks with China Making ‘Big Progress’ February 17, 2019
  • NYC’s Chinatown Welcomes Year of the Pig With Vvibrant Parade February 17, 2019
  • UAE’s Conglomerate Interested in Investing in Cambodia’s Different Sectors February 16, 2019
 

Search

Archives

 

About Us

Cambodia Tribune is a website which acts as an information bank in which news and press releases from various sources are updated on a regular basis. The information is associated with Cambodia and features national news, business news, technological news and other news coverage.
 

©2014 Cambodian Tribune

Menu

  • About Us
  • Contact Us
  • Submit News